{"pmid":32416633,"title":"Management of Hepatocellular Cancer in the time of SARS-CoV-2.","text":["Management of Hepatocellular Cancer in the time of SARS-CoV-2.","As COVID-19 the disease caused by SARS-CoV-2 continues to have a profound impact on global health, there have been a number of guidelines recently published addressing the management of patients with liver disease during the COVID-19 pandemic including the recently published EASL-ESCMID Position Paper, guidelines issued by the International Liver Cancer Association and the American Association for the Study of Liver Diseases (1-3). All publications present a sound discussion regarding the challenges face by both patients and clinicians alike in the management of chronic liver disease in the setting of this ongoing pandemic.","Liver Int","Sharma, Rohini","Pinato, David J","32416633"],"abstract":["As COVID-19 the disease caused by SARS-CoV-2 continues to have a profound impact on global health, there have been a number of guidelines recently published addressing the management of patients with liver disease during the COVID-19 pandemic including the recently published EASL-ESCMID Position Paper, guidelines issued by the International Liver Cancer Association and the American Association for the Study of Liver Diseases (1-3). All publications present a sound discussion regarding the challenges face by both patients and clinicians alike in the management of chronic liver disease in the setting of this ongoing pandemic."],"journal":"Liver Int","authors":["Sharma, Rohini","Pinato, David J"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416633","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/liv.14517","keywords":["covid-19","tace","ablation","hepatocellular carcinoma","surgery","tyrosine kinase inhibitors"],"topics":["Prevention"],"weight":1,"_version_":1666994545879941120,"score":9.490897,"similar":[{"pmid":32349198,"title":"Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.","text":["Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.","In this paper, we aim to provide professional guidance to clinicians who are managing patients with chronic liver disease during the current coronavirus disease 2019 (COVID-19) pandemic in Singapore. We reviewed and summarised the available relevant published data on liver disease in COVID-19 and the advisory statements that were issued by major professional bodies, such as the American Association for the Study of Liver Diseases and European Association for the Study of the Liver, contextualising the recommendations to our local situation.","Singapore Med J","Chang, Jason Pik Eu","Wong, Yu Jun","Yang, Wei Lyn","Lim, Kieron Boon Leng","Tan, Poh Seng","Ho, Gim Hin","Yip, Benjamin Cherng Hann","Li, James Weiquan","Chong, Chern Hao","Ong, David Eng Hui","Chua, Tju Siang","Vu, Charles Kien Fong","Gwee, Kok Ann","Ang, Tiing Leong","Tan, Chee Kiat","32349198"],"abstract":["In this paper, we aim to provide professional guidance to clinicians who are managing patients with chronic liver disease during the current coronavirus disease 2019 (COVID-19) pandemic in Singapore. We reviewed and summarised the available relevant published data on liver disease in COVID-19 and the advisory statements that were issued by major professional bodies, such as the American Association for the Study of Liver Diseases and European Association for the Study of the Liver, contextualising the recommendations to our local situation."],"journal":"Singapore Med J","authors":["Chang, Jason Pik Eu","Wong, Yu Jun","Yang, Wei Lyn","Lim, Kieron Boon Leng","Tan, Poh Seng","Ho, Gim Hin","Yip, Benjamin Cherng Hann","Li, James Weiquan","Chong, Chern Hao","Ong, David Eng Hui","Chua, Tju Siang","Vu, Charles Kien Fong","Gwee, Kok Ann","Ang, Tiing Leong","Tan, Chee Kiat"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32349198","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.11622/smedj.2020069","keywords":["covid-19","sars-cov2","hepatology"],"locations":["Singapore","Singapore"],"countries":["Singapore"],"countries_codes":["SGP|Singapore"],"topics":["Prevention"],"weight":1,"_version_":1666138494974558210,"score":202.59502},{"pmid":32362732,"pmcid":"PMC7195368","title":"Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19.","text":["Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19.","Coronavirus disease 2019 (COVID-19), which started in December 2019 in China, has resulted in a pandemic leading to significant morbidity and mortality across the globe. Although it mainly causes respiratory symptoms, respiratory failure and death due to multiorgan failure, there is evolving evidence to suggest gastrointestinal (GI) and liver involvement by this virus. Owing to this, health-care professionals taking care of GI and liver diseases are also at an increased risk of getting exposed. Hence, there is a need for protocols to be prepared to guide the handling of COVID-19 patients by the GI and liver specialists, as well as to manage the pre-existing GI and liver diseases during the ongoing pandemic. We present here the guidelines prepared jointly by the three Indian professional bodies in the field of GI diseases, namely the Society of Gastrointestinal Endoscopy of India, Indian Society of Gastroenterology, and Indian National Association for the Study of the Liver.","J Clin Exp Hepatol","Philip, Mathew","Lakhtakia, Sundeep","Aggarwal, Rakesh","Madan, Kaushal","Saraswat, Vivek","Makharia, Govind","32362732"],"abstract":["Coronavirus disease 2019 (COVID-19), which started in December 2019 in China, has resulted in a pandemic leading to significant morbidity and mortality across the globe. Although it mainly causes respiratory symptoms, respiratory failure and death due to multiorgan failure, there is evolving evidence to suggest gastrointestinal (GI) and liver involvement by this virus. Owing to this, health-care professionals taking care of GI and liver diseases are also at an increased risk of getting exposed. Hence, there is a need for protocols to be prepared to guide the handling of COVID-19 patients by the GI and liver specialists, as well as to manage the pre-existing GI and liver diseases during the ongoing pandemic. We present here the guidelines prepared jointly by the three Indian professional bodies in the field of GI diseases, namely the Society of Gastrointestinal Endoscopy of India, Indian Society of Gastroenterology, and Indian National Association for the Study of the Liver."],"journal":"J Clin Exp Hepatol","authors":["Philip, Mathew","Lakhtakia, Sundeep","Aggarwal, Rakesh","Madan, Kaushal","Saraswat, Vivek","Makharia, Govind"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362732","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jceh.2020.04.001","keywords":["covid-19","india","endoscopy","guidance","liver"],"locations":["China","multiorgan","Indian","Indian"],"countries":["India","China"],"countries_codes":["IND|India","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138496021037056,"score":144.66231},{"pmid":32425991,"pmcid":"PMC7233236","title":"The liver in times of COVID-19: What hepatologists should know.","text":["The liver in times of COVID-19: What hepatologists should know.","The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver aiming to provide hepatologists with updated information to face this pandemic.","Ann Hepatol","Ridruejo, Ezequiel","Soza, Alejandro","32425991"],"abstract":["The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver aiming to provide hepatologists with updated information to face this pandemic."],"journal":"Ann Hepatol","authors":["Ridruejo, Ezequiel","Soza, Alejandro"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425991","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.aohep.2020.05.001","keywords":["ace2, angiotensin-converting enzyme 2","alt, alanine aminotransferase","ards, acute respiratory distress syndrome","ast, aspartate aminotransferase","cdc, centers for disease control and prevention","covid-19, coronavirus disease 2019","evd, ebola virus disease","hbv, hepatitis b virus","hcc, hepatocellular carcinoma","icu, intensive care unit","il, interleukin","ilca, international liver cancer association","mafld, metabolic associated fatty liver diseases","nafld, non-alcoholic fatty liver disease","niddk, national institute of diabetes and digestive and kidney diseases","rdrp, rna-dependent rna polymerase","sars-cov-2","sars-cov-2, severe acute respiratory syndrome coronavirus 2","tnf-alpha, tumor necrosis factor-alpha","who, world health organization","coronavirus","immunosuppression","liver disease","nsp, non-structural proteins","transplantation, cirrhosis"],"topics":["Treatment"],"weight":1,"_version_":1667352728923275264,"score":138.54446},{"pmid":32277387,"pmcid":"PMC7146012","title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","text":["Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.","Hepatol Int","Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George","32277387"],"abstract":["Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic."],"journal":"Hepatol Int","authors":["Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277387","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10043-z","keywords":["2019-ncov","covid-19","liver transplantation","management"],"locations":["Beijing","China","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1666138491597094912,"score":137.19981},{"pmid":32338017,"title":"COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.","text":["COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.","The purpose of this rapid review is to provide an update on the impact of SARS-CoV-2 infection on Gastroenterology and Hepatology departments, our patients, and our new way of working. The gastrointestinal tract and the liver are affected by SARS-CoV-2, especially in patients with immunosuppressive therapies. Patients with liver transplantation should be followed closely. Digestive endoscopy is a high-risk procedure for the transmission of SARS-CoV-2. While the pandemic lasts, we must adapt its indications and promote protective measures for patients and healthcare professionals alike. The COVID-19 pandemic has changed our priorities and the way we work, although we do not know what the repercussions will be after normality is reinstated.","Rev Esp Enferm Dig","Crespo, Javier","Iglesias-Garcia, Julio","Hinojosa Del Val, Joaquin E","Garcia Garcia, Federico","Gil de Miguel, Angel","Fernandez Carrillo, Carlos","Ampuero, Javier","Perez-Cuadrado Martinez, Enrique","32338017"],"abstract":["The purpose of this rapid review is to provide an update on the impact of SARS-CoV-2 infection on Gastroenterology and Hepatology departments, our patients, and our new way of working. The gastrointestinal tract and the liver are affected by SARS-CoV-2, especially in patients with immunosuppressive therapies. Patients with liver transplantation should be followed closely. Digestive endoscopy is a high-risk procedure for the transmission of SARS-CoV-2. While the pandemic lasts, we must adapt its indications and promote protective measures for patients and healthcare professionals alike. The COVID-19 pandemic has changed our priorities and the way we work, although we do not know what the repercussions will be after normality is reinstated."],"journal":"Rev Esp Enferm Dig","authors":["Crespo, Javier","Iglesias-Garcia, Julio","Hinojosa Del Val, Joaquin E","Garcia Garcia, Federico","Gil de Miguel, Angel","Fernandez Carrillo, Carlos","Ampuero, Javier","Perez-Cuadrado Martinez, Enrique"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338017","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.17235/reed.2020.7128/2020","topics":["Prevention"],"weight":1,"_version_":1666138494167154688,"score":135.68393}]}